Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, provides drug discovery and development services in Japan and internationally. It offers pre-clinical laboratory services, such as good laboratory practice inspections; general and specific toxicity studies; pathological examinations; PK/PD of biopharmaceuticals, immunotoxicity tests, and antibody production; reproductive and developmental toxicity studies; pharmacology and pharmacological efficacy studies; and imaging services. The company also engages in the establishment and validation of analytical methods, analysis of biological samples, and calculation of pharmacokinetic parameters; and provides absorption, distribution, metabolism, and excretion studies using radioisotope-labeled compounds. In addition, it provides site management organization services for clinical trials; clinical contract research organization services; and translational research services, including research and development of nasal delivery systems, nucleic acid adjuvants, and regenerative medicines. The company was founded in 1957 and is headquartered in Tokyo, Japan.
What is Shin Nippon Biomedical Laboratories stock price today?▼
The current price of YB3.STU is €7.9 EUR — it has decreased by -0% in the past 24 hours. Watch Shin Nippon Biomedical Laboratories stock price performance more closely on the chart.
What is Shin Nippon Biomedical Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Shin Nippon Biomedical Laboratories stocks are traded under the ticker YB3.STU.
Is Shin Nippon Biomedical Laboratories stock price growing?▼
YB3.STU stock has risen by +5.33% compared to the previous week, the month change is a -7.06% fall, over the last year Shin Nippon Biomedical Laboratories has showed a +2.6% increase.
When is the next Shin Nippon Biomedical Laboratories earnings date?▼
Shin Nippon Biomedical Laboratories is going to release the next earnings report on May 11, 2026.
What were Shin Nippon Biomedical Laboratories earnings last quarter?▼
YB3.STU earnings for the last quarter are 0.16 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Shin Nippon Biomedical Laboratories have?▼
As of April 11, 2026, the company has 1,050 employees.
In which sector is Shin Nippon Biomedical Laboratories located?▼
Shin Nippon Biomedical Laboratories operates in the Health & Wellness sector.
When did Shin Nippon Biomedical Laboratories complete a stock split?▼
Shin Nippon Biomedical Laboratories has not had any recent stock splits.
Where is Shin Nippon Biomedical Laboratories headquartered?▼
Shin Nippon Biomedical Laboratories is headquartered in Tokyo, Japan.